viral hepatitis overview and prevention Flashcards

(52 cards)

1
Q

HAV: source

A

oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HBV: source

A

blood/blood-derived, body fluids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HCV: source

A

blood/blood-derived

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HAV transmission route

A

fecal-oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HBV transmission route

A

percutaneous, permucosal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HCV transmission route

A

percutaneous, permucosal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HAV: chronic infxn?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HBV: chronic infxn?

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HCV: chronic infxn?

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HAV: acute liver failure?

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HBV: acute liver failure?

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HCV: acute liver failure?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HAV: general prevention?

A

pre/post-exposure immunization, immune globulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HBV: general prevention?

A

pre/post-exposure immunization, immune globulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HCV: general prevention?

A

donor screening, risk behavior modification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

signs of acute liver dysfunction

A

yellow eyes/skin, abdominal pain, pale stools, dark urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

hepatitis A risk factors

A

travel to endemic areas, sexual contact, contaminated food, contact with infected people, handling non-human primates, homelessness. highest risk: injecting or non injecting drug use, unstable housing/homeless, MSM, incarceration, liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

HBV risk factors

A

IV drug users, blood transfusions, household contact with infected individuals, healthcare workers, patients undergoing dialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HCV risk factors

A

blood transfusions, healthcare workers, multiple sex partners, IV drug users, healthcare workers, piercing/tattooing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

chronic complications of viral hepatitis if left untreated

A

hepatocellular carcinoma, end stage liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

viral hepatitis risk reduction

A

hygiene, universal precautions, needle exchange

22
Q

adult vaccination for hepatitis A

A

non-IVDU, homelessness, work-related, contact with international adoptee, settings, HIV, MSM, chronic liver disease, travel, pregnancy, IVDU

23
Q

adult vaccination for hepatitis B

A

all adults 19-59 should get vaccinated. adults 60+ with risk factors should get vaccinated. adults 60+ may get vaccinated without known risk factors.

24
Q

hepatitis A childhood immunization

A

> 12 months. 2 dose series, 6 months apart

25
hepatitis B childhood immunization
birth, 1-2 mo, 6-18 mo (0,1,6)
26
HAV pre exposure prophylaxis: when should you get VACCINE for travel
healthy, >6 months of age, any time pre-departure
27
special note for infants 6-12 months in HAV pre exposure prophylaxis
pre-exposure vaccine does not count towards standard childhood immunization.
28
when should you get IMMUNOGLOBULIN for travel HAV pre exposure prophylaxis
infants <6 months
29
when should you get immunoglobin + vaccine for travel HAV exposure pre prophylaxis
>40 years old, CLD, immunocompromised, travel in <2 weeks
30
dose of IG for <1 month of travel
0.1 mL/kg IM
31
dose of IG for 1-2 months of travel
0.2 mL/kg IM
32
dose of IG for >2 months of travel
0.2 mL/kg IM, repeat q2months
33
when to initiate drugs in pregnancy to prevent HBV transmission based on a number
HBV DNA >200,000
34
when to start drugs in pregnancy to prevent HBV transmission based on time
28-32 weeks gestation
35
which drugs for pregnancy to prevent HBV transmission
lamivudine, telbivudine, tenofovir DF
36
how long to continue HBV medications post partum
0-3 months, breastfeeding is not contraindicated. monitor every 3 months post DC for 6 months
37
how soon to give IG or vaccine for HAV post exposure
2 weeks
38
when to give IG for HAV post exposure
<12 months, >40 years, immunocompromisd, CLD, vaccine allergy
39
dose of IG for HAV post exposure
0.1 mL/kg IM
40
when to give vaccine for HAV post exposure
12 months-40 years old, healthy, single dose
41
when to give HBV post exposure prophylaxis
perinatal, sexual, health care worker
42
infants born to HBV infected mothers should receive ____
HBIG and HBV vaccine both within 12 hours of birth. should additionally receive vaccine at 1 and 6 months
43
people exposed to HBV through sexual contact should receive what prophylaxis
HBIG within 14 days, HBV vaccine at 0, 1, 6 months
44
HCW exposed to HBV should receive what prophylaxis
HBIG within 24 hours, HBV vaccine within 7 days, complete series or 2nd dose of HBIG
45
risks for HBV reactivation
chemo, stem cell transplant, immunosuppression, HCV DAA therapy
46
for moderate and high risk groups to HBV reactivation, how long to give prophylactic treatment
6-12 months
47
which agents are preferred for HBV reactivation prophylaxis
tenofovir and entecavir
48
which immunosuppression drugs have a high risk of HBV reactivation
B-cell depleting: rituximab
49
which immunosuppression drugs have a moderate risk of HBV reactivation
TNF alpha inhibitors: adalimumab
50
which immunosuppression drugs have a low risk of HBV reactivation
oral steroids <1 week, prednisone <10 mg for >4 weeks, intra-articular steroids. no prophylaxis indicated.
51
what is a black box warning for all HCV medications
HBV reactivation
52
hepatitis C prevention?
avoidance, monitoring.